Journal of Peking University (Health Sciences) ›› 2020, Vol. 52 ›› Issue (6): 1014-1022. doi: 10.19723/j.issn.1671-167X.2020.06.005
Previous Articles Next Articles
Shi-xiong WEI1,2,Shu-jia LI1,2,Yi LIU1,2,△()
CLC Number:
[1] | Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis[J]. Lancet, 2011,377(9783):2138-2149. |
[2] |
Thierry S, Fautrel B, Lemelle I, et al. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review[J]. Joint Bone Spine, 2014,81(2):112-117.
doi: 10.1016/j.jbspin.2013.09.003 pmid: 24210707 |
[3] |
Palman J, Shoop-Worrall S, Hyrich K, et al. Update on the epidemiology, risk factors and disease outcomes of Juvenile idiopathic arthritis[J]. Best Pract Res Clin Rheumatol, 2018,32(2):206-222.
pmid: 30527427 |
[4] | Stoll ML, Cron RQ. Treatment of juvenile idiopathic arthritis: a revolution in care[J/OL]. Pediatr Rheumatol Online J, 2014, 23: 12-13[2020-04-02]. https://pubmed.ncbi.nlm.nih.gov/247826831. |
[5] |
Ruperto N, Martini A. Current and future perspectives in the management of juvenile idiopathic arthritis[J]. Lancet Child Adolesc Health, 2018,2(5):360-370.
doi: 10.1016/S2352-4642(18)30034-8 pmid: 30169269 |
[6] |
Shenoi S. Juvenile Idiopathic arthritis changing times, changing terms, changing treatments[J]. Pediatr Rev, 2017,38(5):221-232.
doi: 10.1542/pir.2016-0148 pmid: 28461613 |
[7] |
Okamoto N, Yokota S, Takei S, et al. Clinical practice guidance for juvenile idiopathic arthritis (JIA) 2018[J]. Mod Rheumatol, 2019,29(1):41-59.
doi: 10.1080/14397595.2018.1514724 pmid: 30126298 |
[8] |
Vanoni F, Minoia F, Malattia C. Biologics in juvenile idiopathic arthritis: a narrative review[J]. Eur J Pediatr, 2017,176(9):1147-1153.
doi: 10.1007/s00431-017-2960-6 pmid: 28725955 |
[9] | Swart JF, de Roock S, Nievelstein RAJ, et al. Bone-marrow derived mesenchymal stromal cells infusion in therapy refractory juvenile idiopathic arthritis patients[J]. Rheumatology (Oxford), 2019,58(10):1812-1817. |
[10] |
Kaminiarczyk-Pyzalka D, Adamczak K, Mikos H, et al. Proinflammatory cytokines in monitoring the course of disease and effectiveness of treatment with etanercept (ETN) of children with oligo and polyarticular juvenile idiopathic arthritis (JIA)[J]. Clin Lab, 2014,60(9):1481-1490.
doi: 10.7754/clin.lab.2013.130734 pmid: 25291944 |
[11] |
Marzetti V, Breda L, Miulli E, et al. Clinical characteristics of juvenile idiopathic arthritis in an area of central Italy: a population-based study[J]. Ann Ig, 2017,29(4):281-292.
pmid: 28569338 |
[12] |
Selvaag AM, Aulie HA, Lilleby V, et al. Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis[J]. Ann Rheum Dis, 2016,75(1):190-195.
doi: 10.1136/annrheumdis-2014-206034 pmid: 25362042 |
[13] |
Akioka S. A better understanding of juvenile idiopathic arthritis with classification criteria[J]. Nihon Rinsho Meneki Gakkai Kaishi, 2016,39(6):513-521.
pmid: 28049960 |
[14] |
Lundberg IE, Tjärnlund A, Bottai M, et al. 2017 European League Against Rheumatism/ American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups[J]. Ann Rheum Dis, 2017,76(12):1955-1964.
doi: 10.1136/annrheumdis-2017-211468 pmid: 29079590 |
[15] |
Gorkem SB, Doria AS, Tse S. Imaging findings of mixed connective tissue disease in children and adolescents: a case series[J]. Jpn J Radiol, 2019,37(5):371-379.
doi: 10.1007/s11604-019-00824-4 pmid: 30875012 |
[16] |
Giancane G, Alongi A, Ravelli A. Update on the pathogenesis and treatment of juvenile idiopathic arthritis[J]. Curr Opin Rheumatol, 2017,29(5):523-529.
pmid: 28538013 |
[17] |
Haas JP, Arbogast M. Therapeutic options in juvenile idiopathic arthritis: Part 1: Nonsurgical treatment[J]. Orthopade, 2018,47(11):912-918.
doi: 10.1007/s00132-018-3645-1 pmid: 30291372 |
[18] |
Foster HE, Marshall N, Myers A, et al. Outcome in adults with juvenile idiopathic arthritis: a quality of life study[J]. Arthritis Rheum, 2003,48(3):767-775.
pmid: 12632431 |
[19] |
Chua-Aguilera CJ, Möller B, Yawalkar N. Skin manifestations of rheumatoid arthritis, juvenile idiopathic arthritis, and spondyloarthritides[J]. Clin Rev Allergy Immunol, 2017,53(3):371-393.
doi: 10.1007/s12016-017-8632-5 pmid: 28752373 |
[20] |
Deslandre C. Juvenile idiopathic arthritis: Definition and classification[J]. Arch Pediatr, 2016,23(4):437-441.
doi: 10.1016/j.arcped.2016.01.005 pmid: 26968301 |
[21] |
Dimitriou C, Boitsios G, Badot V, et al. Imaging of juvenile idiopathic arthritis[J]. Radiol Clin North Am, 2017,55(5):1071-1083.
pmid: 28774449 |
[22] |
Nakamura J, Nagashima T, Yoshio T, et al. Arthritis mutilans in a patient with juvenile idiopathic arthritis[J]. Intern Med, 2015,54(6):689-690.
pmid: 25786469 |
[23] |
Rebane K, Orenius T, Ristolainen L, et al. Pain interference and associated factors in young adults with juvenile idiopathic arthritis[J]. Scand J Rheumatol, 2019,48(5):408-414.
doi: 10.1080/03009742.2019.1596308 pmid: 31170850 |
[24] | Tollisen A, Selvaag AM, Aulie HA, et al. Physical functioning, pain, and health-related quality of life in adults with juvenile idiopathic arthritis: a longitudinal 30-year followup study[J]. Arthritis Care Res (Hoboken), 2018,70(5):741-749. |
[25] |
Conti F, Pontikaki I, D’Andrea M, et al. Patients with juvenile idiopathic arthritis become adults: the role of transitional care[J]. Clin Exp Rheumatol, 2018,36(6):1086-1094.
pmid: 29652654 |
[26] |
Leon L, Gomez A, Vadillo C, et al. Severe adverse drug reactions to biological disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis in clinical practice[J]. Clin Exp Rheumatol, 2018,36(1):29-35.
pmid: 28598787 |
[27] |
Welsing PM, van Gestel AM, Swinkels HL, et al. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis[J]. Arthritis Rheum, 2001,44(9):2009-2017.
doi: 10.1002/1529-0131(200109)44:9<2009::AID-ART349>3.0.CO;2-L pmid: 11592361 |
[28] |
Elkayam O, Ophir J, Yaron M, et al. Psoriatic arthritis: interrelationships between skin and joint manifestations related to onset, course and distribution[J]. Clin Rheumatol, 2000,19(4):301-305.
doi: 10.1007/pl00011173 pmid: 10941813 |
[29] |
Matsumoto T, Matsui T, Hirano F, et al. Disease activity, treatment and long-term prognosis of adult juvenile idiopathic arthritis patients compared with rheumatoid arthritis patients[J]. Observational Study Mod Rheumatol, 2020,30(1):78-84.
pmid: 30499364 |
[30] | McErlane F, Foster HE, Davies R, et al. Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register[J]. Rheumatology (Oxford), 2013,52(10):1905-1913. |
[31] | Mourão AF, Santos MJ, Melo Gomes JA, et al. Effectiveness and long-term retention of anti-tumour necrosis factor treatment in juvenile and adult patients with juvenile idiopathic arthritis: data from Reuma.pt[J]. Rheumatology (Oxford), 2016,55(4):697-703. |
[1] | Li-jia MA,Pan-pan HU,Xiao-guang LIU. Spinal metastases combined with leptomeningeal metastasis: A case report [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 563-566. |
[2] | Ting WANG,Qiao-sheng LI,Hao-ran LIU,Wei-yan JIAN. Urban-rural differentials in the relationship between personality traits and changes in depressive symptoms [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 385-391. |
[3] | Rui LIU,Jin-xia ZHAO,Liang YAN. Clinical characteristics of patients with rheumatoid arthritis complicated with venous thrombosis of lower extremities [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1079-1085. |
[4] | Er-shu BO,Peng HONG,Yu ZHANG,Shao-hui DENG,Li-yuan GE,Min LU,Nan LI,Lu-lin MA,Shu-dong ZHANG. Clinicopathological features and prognostic analysis of papillary renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2022, 54(4): 615-620. |
[5] | XIA Fang-fang,LU Fu-ai,LV Hui-min,YANG Guo-an,LIU Yuan. Clinical characteristics and related factors of systemic lupus erythematosus with interstitial pneumonia [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 266-272. |
[6] | GAO Lan, FAN Yong, ZHANG Zhuo-li△. Clinical analysis of 31 ankylosing spondylitis patients with malignancies [J]. Journal of Peking University(Health Sciences), 2015, 47(6): 962-965. |
[7] | TANG Shun, GUO Wei, YANG Rong-Li, TANG Xiao-Dong, LI Da-Sen, DONG Sen. Surgical treatment and prognostic analysis of osteosarcoma in adults older than 40 years [J]. Journal of Peking University(Health Sciences), 2015, 47(1): 165-169. |
|